St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up.

St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Abstract Text:

R Ejsted,N J Olsen,P Krogh,

Thirty-eight St. Georgs hinged-knee arthroplasties were studied with a follow-up of 2.5-8 years; 86.8% of the patients obtained an excellent or a good result, and 7.9% of the arthroplasties were failures. There was an infection rate of 3.8% and 3.8% loose prostheses. Among the failures there were two infected arthroplasties. One was arthrodesed, resulting in a pseudoarthrosis and one was successfully revised. One traumatic loosening lead to arthrodesis. It is concluded that hinged-knee arthroplasty under special circumstances may be a useful procedure.

St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Publishing Authors By Initials

R Ejsted,NJ Olsen,P Krogh,

For similar surgical procedures, operative: reoperation research abstracts see: surgical procedures, operative: reoperation research

PUBMED ID PMID:

MEDLINE DATE:

St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of orthopaedic and traumatic surgery. Arc

VOLUME: 104

Page Numbers: 218-23

Journal Abbreviation:

ISSN: 0344-8444

DAY: 21

MONTH: 02

YEAR: 1985

St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7803037

St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Keywords Mesh Terms:

KEYWORDS: Reoperation

MESH TERMS: etiology

Chemical & Substance for Abstract: St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Orthop Trauma Surg

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

St Georg hinged-knee prosthesis A 25- to 8-year follow-up Related Publications

• An evolutionary method for learning HMM structure: prediction of protein secondary structure.
• Asap: a framework for over-representation statistics for transcription factor binding sites.
• CONTACT ECZEMA CAUSED BY TRUE TEAK (TECTONA GRANDIS). A FOLLOW-UP STUDY OF A PREVIOUS EPIDEMIOLOGICAL INVESTIGATION, AND A STUDY INTO THE SENSITIZING EFFECT OF VARIOUS TEAK EXTRACTS.
• Casual associations of mycotoxic nephropathy.
• Cystadenoma of the mandible.
• Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study.
• Heteroplastic bone formation in the cheek.
• Hidden markov models for prediction of protein features.
• Intragenomic matching reveals a huge potential for miRNA-mediated regulation in plants.
• MASTR: multiple alignment and structure prediction of non-coding RNAs using simulated annealing.
• Mandibular asymmetry: report of an unusual case and the surgical management.
• Modeling promoter grammars with evolving hidden Markov models.
• Prevention of dry sockets.
• Spontaneous toxic nephropathy in poultry associated with ochratoxin A.
• St Georg modular knee prosthesis. A two-and-a-half to six-year follow-up.
• St. Georg hinged-knee prosthesis. A 2.5- to 8-year follow-up.
• The nerve fibre layer symmetry test: computerized evaluation of human retinal nerve fibre layer thickness as measured by optical coherence tomography.
• Use of thiopental sodium in dental surgery.
• What are artificial neural networks?
• [Chlorination of drinking water--guarantee for life or health hazard?]
• [Griseofulvin, an oral antibiotic with antimycotic effects.]
• [Malignant melanoma--a warning. How to reduce mortality?]
• [Micronized griseofulvin. A comparative trial in favus.]
• [Radiation necrosis of the cerebellum after a single administration of high dosage roentgen irradiation.]
• [Treatment of dermatomycosis with griseofulvin.]
• [Trilafon treatment of 51 male patients.]